|
1.
|
A JemalR SiegelJ XuE WardCancer
statisticsCA Cancer J Clin602773002010
|
|
2.
|
A JemalF BrayMM CenterJ FerlayE WardD
FormanGlobal cancer statisticsCA Cancer J
Clin616990201110.3322/caac.20107
|
|
3.
|
K PliarchopoulouD PectasidesPancreatic
cancer: Current and future treatment strategiesCancer Treat
Rev35431436200910.1016/j.ctrv.2009.02.00519328630
|
|
4.
|
A MaitraRH HrubanPancreatic cancerAnnu Rev
Pathol3157188200810.1146/annurev.pathmechdis.3.121806.154305
|
|
5.
|
J ShenMD PersonJ ZhuJL AbbruzzeseD
LiProtein expression profiles in pancreatic adenocarcinoma compared
with normal pancreatic tissue and tissue affected by pancreatitis
as detected by two-dimensional gel electrophoresis and mass
spectrometryCancer
Res6490189026200410.1158/0008-5472.CAN-04-3262
|
|
6.
|
U SteinW WaltherF ArltMACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasisNat Med155967200910.1038/nm.188919098908
|
|
7.
|
F ArltU SteinColon cancer metastasis:
MACC1 and Met as metastatic pacemakersInt J Biochem Cell
Biol4123562359200910.1016/j.biocel.2009.08.00119666136
|
|
8.
|
A ShirahataK ShinmuraY KitamuraMACC1 as a
marker for advanced colorectal carcinomaAnticancer
Res3026892692201020682999
|
|
9.
|
A ShirahataW FanK SakurabaMACC 1 as a
marker for vascular invasive hepatocellular carcinomaAnticancer
Res31777780201121498695
|
|
10.
|
G ChundongH UramotoT OnitsukaMolecular
diagnosis of MACC1 status in lung adenocarcinoma by
immunohistochemical analysisAnticancer
Res3111411145201121508357
|
|
11.
|
H ShimokawaH UramotoT
OnitsukaOverexpression of MACC1 mRNA in lung adenocarcinoma is
associated with postoperative recurrenceJ Thorac Cardiovasc
Surg141895898201110.1016/j.jtcvs.2010.09.04421093878
|
|
12.
|
A ShirahataM SakataY KitamuraMACC 1 as a
marker for peritoneal-disseminated gastric carcinomaAnticancer
Res3034413444201020944120
|
|
13.
|
LH SobinWC WittekindTNM Classification of
Malignant Tumours (UICC)6th editionWiley-LissNew York93962002
|
|
14.
|
DG AltmanB LausenW SauerbreiM
SchumacherDangers of using ‘optimal’ cutpoints in the evaluation of
prognostic factorsJ Natl Cancer Inst868298351994
|
|
15.
|
A ArltA GehrzS MuerkosterRole of NF-kappaB
and Akt/PI3K in the resistance of pancreatic carcinoma cell lines
against gemcitabine-induced cell
deathOncogene2232433251200310.1038/sj.onc.120639012761494
|
|
16.
|
J QiuP HuangQ LiuIdentification of MACC1
as a novel prognostic marker in hepatocellular carcinomaJ Transl
Med9166201110.1186/1479-5876-9-16621955323
|
|
17.
|
R ZhangH ShiZ ChenQ WuF RenH HuangEffects
of metastasis-associated in colon cancer 1 inhibition by small
hairpin RNA on ovarian carcinoma OVCAR-3 cellsJ Exp Clin Cancer
Res3083201110.1186/1756-9966-30-8321923915
|
|
18.
|
D ShookR KellerMechanisms, mechanics and
function of epithelial-mesenchymal transitions in early
developmentMech
Dev12013511383200310.1016/j.mod.2003.06.00514623443
|
|
19.
|
J YangRA WeinbergEpithelial-mesenchymal
transition: at the crossroads of development and tumor
metastasisDev
Cell14818829200810.1016/j.devcel.2008.05.00918539112
|
|
20.
|
AN ShahJM SummyJ ZhangSI ParkNU ParikhGE
GallickDevelopment and characterization of gemcitabine-resistant
pancreatic tumor cellsAnn Surg
Oncol1436293637200710.1245/s10434-007-9583-517909916
|
|
21.
|
Z WangY LiD KongAcquisition of
epithelial-mesenchymal transition phenotype of
gemcitabine-resistant pancreatic cancer cells is linked with
activation of the notch signaling pathwayCancer
Res6924002407200910.1158/0008-5472.CAN-08-4312
|
|
22.
|
T ArumugamV RamachandranKF
FournierEpithelial to mesenchymal transition contributes to drug
resistance in pancreatic cancerCancer
Res6958205828200910.1158/0008-5472.CAN-08-281919584296
|
|
23.
|
JL BosRas oncogenes in human cancer: a
reviewCancer Res494682468919892547513
|
|
24.
|
F CalvoL Agudo-IbanezP CrespoThe Ras-ERK
pathway: understanding site-specific signaling provides hope of new
anti-tumor
therapiesBioessays32412421201010.1002/bies.20090015520414899
|
|
25.
|
T DeramaudtAK RustgiMutant KRAS in the
initiation of pancreatic cancerBiochim Biophys
Acta175697101200516169155
|
|
26.
|
S RejibaS WackM AprahamianA HajriK-ras
oncogene silencing strategy reduces tumor growth and enhances
gemcitabine chemotherapy efficacy for pancreatic cancer
treatmentCancer
Sci9811281136200710.1111/j.1349-7006.2007.00506.x
|
|
27.
|
K NishidaT HiranoThe role of Gab family
scaffolding adapter proteins in the signal transduction of cytokine
and growth factor receptorsCancer
Sci9410291033200310.1111/j.1349-7006.2003.tb01396.x14662016
|
|
28.
|
H GuBG NeelThe ‘Gab’ in signal
transductionTrends Cell Biol131221302003
|
|
29.
|
A YartM LaffargueP MayeuxA critical role
for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the
activation of ras and mitogen-activated protein kinases by
epidermal growth factorJ Biol
Chem27688568864200110.1074/jbc.M00696620011134009
|
|
30.
|
JM CunnickS MengY RenRegulation of the
mitogen-activated protein kinase signaling pathway by SHP2J Biol
Chem27794989504200210.1074/jbc.M11054720011779868
|
